BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
227 results:

  • 1. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition.
    Nan Y; Wu X; Luo Q; Chang W; Zhao P; Zhang L; Liu Z
    Proc Natl Acad Sci U S A; 2024 May; 121(19):e2315348121. PubMed ID: 38701117
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of core genes of craniopharyngioma angiogenesis based on single-cell nuclear transcriptome sequencing.
    Zhang J; Xu L; Ye J; Xu C; Wu B; Wu J; Hong T
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):136-141. PubMed ID: 38650143
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. NNT-AS1 in CAFs-derived exosomes promotes progression and glucose metabolism through miR-889-3p/HIF-1α in pancreatic adenocarcinoma.
    Zhang P; Wang Q; Lu W; Zhang F; Wu D; Sun J
    Sci Rep; 2024 Mar; 14(1):6979. PubMed ID: 38521881
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.
    Feng S; Ding B; Dai Z; Yin H; Ding Y; Liu S; Zhang K; Lin H; Xiao Z; Shen Y
    J Transl Med; 2024 Mar; 22(1):280. PubMed ID: 38491511
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
    Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
    J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.
    Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
    Cell Signal; 2024 Apr; 116():111044. PubMed ID: 38211842
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Research progress on the mechanism of glycolysis in ovarian cancer.
    Li C; Liu FY; Shen Y; Tian Y; Han FJ
    Front Immunol; 2023; 14():1284853. PubMed ID: 38090580
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in Thyroid cancer Cells.
    Zhang Y; Han Y; Dong J; Li F; Sun Y
    Balkan Med J; 2024 Jan; 41(1):23-29. PubMed ID: 38044598
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hypoxia mediates immune escape of pancreatic cancer cells by affecting miR-1275/AXIN2 in natural killer cells.
    Ou Z; Lu Y; Xu D; Luo Z
    Front Immunol; 2023; 14():1271603. PubMed ID: 38035113
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hypoxia promotes the growth and metastasis of ovarian cancer cells by suppressing ferroptosis via upregulating SLC2A12.
    Li M; Li L; Cheng X; Li L; Tu K
    Exp Cell Res; 2023 Dec; 433(2):113851. PubMed ID: 37940066
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cytotoxic effects of Phenformin on ovarian cancer cells: expression of HIF-1α and PDK1 in the hypoxic microenvironment.
    Gunaydin B; Yigitturk G; Elbe H
    Rom J Morphol Embryol; 2023; 64(3):355-361. PubMed ID: 37867353
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway.
    Wang D; Liu X; Li M; Ning J
    Mol Carcinog; 2024 Feb; 63(2):238-252. PubMed ID: 37861358
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic cancer.
    Chien TL; Wu YC; Lee HL; Sung WW; Yu CY; Chang YC; Lin CC; Wang CC; Tsai MC
    Medicina (Kaunas); 2023 Aug; 59(9):. PubMed ID: 37763649
    [No Abstract]    [Full Text] [Related]  

  • 14. Stem cell factor modulates HIF-1α levels and diminishes 5-FU sensitivity in 5-FU resistant pancreatic cells by altering the anabolic glucose metabolism.
    Xiang F; Luo F
    J Biochem Mol Toxicol; 2023 Dec; 37(12):e23487. PubMed ID: 37718545
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary.
    Mori H; Nishida H; Kusaba T; Kawamura K; Oyama Y; Daa T
    Medicine (Baltimore); 2023 Sep; 102(37):e35301. PubMed ID: 37713813
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
    Xun J; Ohtsuka H; Hirose K; Douchi D; Nakayama S; Ishida M; Miura T; Ariake K; Mizuma M; Nakagawa K; Morikawa T; Furukawa T; Unno M
    BMC Cancer; 2023 Sep; 23(1):835. PubMed ID: 37674118
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming.
    Tan S; Yu H; Xu Y; Zhao Y; Lou G
    Med Oncol; 2023 Aug; 40(9):272. PubMed ID: 37596446
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression.
    Zhu C; Hu H; Ma Y; Xiong S; Zhu D
    Cell Biol Int; 2023 Nov; 47(11):1835-1842. PubMed ID: 37545183
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma.
    Chen M; Cen K; Song Y; Zhang X; Liou YC; Liu P; Huang J; Ruan J; He J; Ye W; Wang T; Huang X; Yang J; Jia Y; Liang X; Shen P; Wang Q; Liang T
    Cancer Lett; 2023 Jul; 567():216285. PubMed ID: 37354982
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance.
    Trocchianesi S; Po A; Citarella A; Spinello Z; Rughetti A; Besharat ZM; Autilio TM; Pecce V; Verrienti A; Elisei R; Durante C; Catanzaro G; Ferretti E
    Biomed Pharmacother; 2023 Aug; 164():114995. PubMed ID: 37301138
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.